apollo
0
Written By Veda Maddala , M Pharmacy
Reviewed By Hari Kumar , MBBS
Non returnable*
COD available

Online payment accepted

rxMedicinePrescription drug

Whats That

tooltip

Composition :

LEUPRORELIN-22.5MG

Manufacturer/Marketer :

Axiommax Oncology Pvt Ltd

Consume Type :

PARENTERAL

Return Policy :

Not Returnable

About Leuprotime 22.5 mg Depot Injection 1's

Leuprotime 22.5 mg Depot Injection 1's belongs to the class of synthetic hormones used in the treatment of prostate cancer in men, endometriosis, and hormone-responsive breast cancer in women. Also, Leuprotime 22.5 mg Depot Injection 1's is used to treat premature puberty in children. Prostate cancer is cancer of the prostate gland (a small gland under the bladder that produces semen) found only in men. The symptoms include difficulty in urination, pain, numbness, or sexual problems.

Leuprotime 22.5 mg Depot Injection 1's contains Leuprorelin, a synthetic hormone that works similarly to the natural hormone, gonadotropin-releasing hormone (GnRH), by acting on the pituitary gland and decreasing the levels of testosterone in men and estrogen in women. Thereby, Leuprotime 22.5 mg Depot Injection 1's is used in the treatment of prostate cancer by inhibiting the growth of the tumor or causing it to shrink.  

Use Leuprotime 22.5 mg Depot Injection 1's as prescribed by your doctor. You are advised to take Leuprotime 22.5 mg Depot Injection 1's for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience pain, redness, swelling, or skin hardening at the injection site, muscle weakness, bone pain, inability to have an erection, breast tenderness, headache, vaginal dryness, changes in breast size, acne, or mood swings. Most of these side effects of Leuprotime 22.5 mg Depot Injection 1's do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Leuprotime 22.5 mg Depot Injection 1's or any other medicines, please tell your doctor. Leuprotime 22.5 mg Depot Injection 1's is contraindicated in pregnant and breastfeeding women. It is advised to use effective contraceptive measures to avoid pregnancy while taking Leuprotime 22.5 mg Depot Injection 1's as it may cause birth defects. Leuprotime 22.5 mg Depot Injection 1's should be used with caution in children. You are recommended to avoid or limit consumption of alcohol with Leuprotime 22.5 mg Depot Injection 1's as it may increase the risk of bone density loss. Drive only if you are alert as Leuprotime 22.5 mg Depot Injection 1's may cause dizziness, drowsiness, or vision disturbances.

Uses of Leuprotime 22.5 mg Depot Injection 1's

Prostate cancer, Breast cancer, Endometriosis, Premature puberty

Directions for Use

Leuprotime 22.5 mg Depot Injection 1's will be administered by a healthcare professional; do not self-administer.

Medicinal Benefits

Leuprotime 22.5 mg Depot Injection 1's contains Leuprorelin which works similarly to the natural hormone, gonadotropin-releasing hormone (GnRH), by acting on the pituitary gland and decreasing the levels of testosterone in men and oestrogen in women. Thereby, Leuprotime 22.5 mg Depot Injection 1's is used in the treatment of prostate cancer by inhibiting the growth of the tumour or causing it to shrink.  Also, Leuprotime 22.5 mg Depot Injection 1's is used to treat hormone-responsive breast cancer in pre and postmenopausal women. By reducing testosterone and oestrogen levels, Leuprotime 22.5 mg Depot Injection 1's delays the onset of puberty in children.

Storage

Store in a cool and dry place away from sunlight

Drug Warnings

If you are allergic to Leuprotime 22.5 mg Depot Injection 1's or any other medicines, please tell your doctor. Leuprotime 22.5 mg Depot Injection 1's is contraindicated in pregnant and breastfeeding women. It is advised to use effective non-hormonal contraceptives such as condoms to avoid pregnancy while taking Leuprotime 22.5 mg Depot Injection 1's as it may cause birth defects. Leuprotime 22.5 mg Depot Injection 1's should be used with caution in children. You are advised to quit smoking as it may increase the risk of prostate cancer. You are recommended to avoid or limit consumption of alcohol with Leuprotime 22.5 mg Depot Injection 1's as it may increase the risk of bone density loss. Drive only if you are alert as Leuprotime 22.5 mg Depot Injection 1's may cause dizziness, drowsiness or vision disturbances.

Diet & Lifestyle Advise

  • Include fish, soy, tomatoes, Brussels sprouts, kale, broccoli, and oils containing omega-3 fatty acids such as olive oil as these foods may reduce the risk of prostate cancer.
  • Avoid grilled meat, red meat, and saturated fat found in animal products, milk, and dairy products as they may increase the risk of prostate cancer.
  • Exercise regularly to lose weight as obesity is also considered a risk factor for prostate cancer.
  • Quit smoking to reduce the risk of prostate cancer.
  • Avoid fast food, fried food, processed meats, refined carbs, and added sugar.

Habit Forming

No

Therapeutic Class

GONADOTROPHIN-RELEASING HORMONE AGONIST

Leuprotime 22.5 mg Depot Injection 1's Substitute

Substitutes safety advice
  • Duplat Depot 22.5 mg Combipack Injection 1's

    by Others

    15686.60per tablet
  • Eligrad Depot 22.5Mg Vail

    by Others

    20411.44per tablet
  • Bdsure 22.5 mg Injection 1's

    by Others

    11453.80per tablet
  • Leugard 22.5 mg Depot Injection 1's

    by Others

    14609.10per tablet
  • Lorisk Depot 22.5 mg Combikit Injection 1's

    by Others

    18500.00per tablet

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Leuprotime 22.5 mg Depot Injection 1's contains Leuprorelin, a synthetic hormone that works similar to the natural hormone, gonadotropin-releasing hormone (GnRH) by acting on the pituitary gland and decreases the levels of testosterone in men and oestrogen in women. Thereby, Leuprotime 22.5 mg Depot Injection 1's is used in the treatment of prostate cancer by inhibiting the growth of tumour or causing it to shrink.

Leuprotime 22.5 mg Depot Injection 1's may stop menstrual periods. However, after 7 to 12 weeks of taking the final dose of injection, periods will resume. Please consult a doctor if you have any concerns regarding this.

Leuprotime 22.5 mg Depot Injection 1's should be used with caution in diabetic patients as it may increase the risk of high blood sugar levels. Therefore, it is advised to regularly monitor blood sugar levels while taking Leuprotime 22.5 mg Depot Injection 1's and inform your doctor if you have diabetes before taking Leuprotime 22.5 mg Depot Injection 1's.

Leuprotime 22.5 mg Depot Injection 1's may be used to treat endometriosis (tissue lining the uterus known as endometrium grows outside the uterus). Leuprotime 22.5 mg Depot Injection 1's reduces oestrogen levels and causes menopause temporarily. Thereby, shrink the tissue outside the uterus or stop its growth.

Leuprotime 22.5 mg Depot Injection 1's may decrease bone density, especially when used for the treatment of premature puberty in children. Therefore, regular monitoring of bone density is recommended while taking Leuprotime 22.5 mg Depot Injection 1's.

Leuprotime 22.5 mg Depot Injection 1's should be used with extreme caution in patients suffering from depression as it may worsen the condition. Therefore, inform your doctor if you have any history of depression before taking Leuprotime 22.5 mg Depot Injection 1's.

Drug-Drug Interactions Checker List

  • MOXIFLOXACIN
  • PROCAINAMIDE
  • QUINIDINE
  • SOTALOL
  • AMIODARONE
  • METHADONE
  • CLOZAPINE

Special Advise

Leuprotime 22.5 mg Depot Injection 1's may cause changes in blood cholesterol levels or affect values in liver functioning tests. Therefore, inform your doctor that you are taking Leuprotime 22.5 mg Depot Injection 1's before undergoing any tests.

Disease/Condition Glossary

Prostate cancer: It is the cancer of the prostate gland (a small gland under the bladder that produces semen) found only in men. The symptoms include difficulty in urination, pain, numbness, or sexual problems. Certain factors increase the risk of prostate cancer, such as the family history of prostate cancer, older age, obesity, or genetic changes.

Breast cancer: It is a type of cancer that develops in breast cells that are stimulated by a female sex hormone called estrogen. Breast cancer may form in lobules (glands that produce milk), ducts of the breast (the pathway that brings milk from glands to the nipple), and in the fatty tissue or the fibrous connective tissue within the breast.

Endometriosis: It is a disorder in which the tissue lining the uterus (endometrium) grows on the ovaries, bowel, or tissues lining the pelvis. The most common symptom is pelvic pain. Other symptoms of endometriosis include lower back pain, painful periods, heavy menstrual bleeding, pain following sexual intercourse, or discomfort with bowel movements.  

Premature puberty: It is a condition in which the signs of puberty (physical changes in which a child’s body matures into an adult body) start early in children, i.e., before 9 years in girls and before 10 years in boys.

Have a query?

whatsapp Floating Button